INVESTMENTS IN UNCONSOLIDATED ENTITIES (Tables)

6 Months Ended

Jun. 30, 2024

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investments

Below is a summary of our investments in unconsolidated real estate entities, including through VIM, as of June 30, 2024 and December 31, 2023, respectively (dollars in thousands):

	Ownership as of (1)		Carrying Amount as of
	June 30, 2024	December 31, 2023	June 30, 2024		December 31, 2023
Investments in unconsolidated real estate entities:
Ventas Life Science & Healthcare Real Estate Fund	20.1%	20.1%	$	262,374	$	264,442
Pension Fund Joint Venture	25.0%	25.0%	19,125		22,169
Research & Innovation Development Joint Venture	53.0%	53.0%	290,619		275,829
Ventas Investment Management platform			572,118		562,440
Atrium Health & Wake Forest Joint Venture	48.5%	48.5%	36,112		35,137
All other (2)	34.0%-37.5%	34.0%-37.5%	614		629
Total investments in unconsolidated real estate entities			$	608,844	$	598,206

______________________________

(1)    The entities in which we have an ownership interest may have less than a 100% interest in the underlying real estate. The ownership percentages in the table reflect our interest in the entities. Joint venture members, including us in some instances, have equity participation rights based on the underlying performance of the investments, which could result in non pro rata distributions.

(2)     Includes investments in parking structures and other de minimis investments in unconsolidated real estate entities.